ArticleNucleic acids research2026
Dual regulation of HEPN RNase in fused MNT-HEPN toxin-antitoxin systems via protein OligoAMPylation and oligomerization.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Enzymatic toxins targeting nucleic acids are a widespread strategy for resolving biological conflicts. Ubiquitous HEPN domain-containing proteins harbor a conserved RNase motif and are found in both prokaryotes and eukaryotes. In prokaryotes, HEPN domain toxins frequently pair with adjacent MNT domain antitoxins to form the prevalent type VII HepT/MntA toxin-antitoxin (TA) system. Here, we identified a group of fused MNT-HEPN proteins (renamed FhepTA) carried by mobile genetic elements in the Shewanella genus; these proteins show high similarity to the HepT/MntA TA systems. When encoded as separate genes, the MntA antitoxin oligoAMPylates the HEPN domain toxin HepT to block its toxicity. While FhepTA toxicity is also blocked by oligoAMPylation, it is additionally regulated by a redox switch involving two unique cysteines within its HEPN domain. Furthermore, the N-terminal MNT domain intrinsically inhibits toxicity by preventing dimerization of the C-terminal HEPN domain. Thus, the fused MNT-HEPN architecture represents a new family of TA modules potentially regulated in both ATP-dependent (via oligoAMPylation) and redox-state-dependent oligomerization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.